High expression of the classical swine fever virus (CSFV) envelope protein E2 by a single amino acid mutation and its embedded in the pseudorabies virus (PRV) vector for immunization

文献类型: 外文期刊

第一作者: Sun, Yang-yang

作者: Sun, Yang-yang;Liu, Ke-shu;Yun, Tao;Ni, Zheng;Zhu, Yin-chu;Chen, Liu;Ye, Wei-cheng;Hua, Jiong-gang;Huo, Su-xin;Wang, Hong-yu;Zhang, Cun;Sun, Yang-yang;Bao, En-dong;Bao, Hai-li

作者机构:

关键词: Pseudorabies virus; Classical swine fever; Bivalent vaccine; A transmembrane region; E2 protein

期刊名称:VIRUS RESEARCH ( 影响因子:5.0; 五年影响因子:4.0 )

ISSN: 0168-1702

年卷期: 2023 年 331 卷

页码:

收录情况: SCI

摘要: Pseudorabies (PR) and classical swine fever (CSF) are economically important infectious diseases in pigs. Most pig farms in China are vaccinated against these two diseases. Gene-deleted pseudorabies virus (PRV) can be used to develop promising and economical multivalent live attenuated viral vector vaccines. It has been reported that recombinant PRV can express a truncated E2 protein (1-338 aa), but it has not been reported that recombinant PRV can express a full-length E2 protein. We constructed nine groups of E2 proteins with different expression forms and found that the E2 protein could be expressed in vitro only when the transmembrane region of E2 was removed and the signal peptide was added. Analysis of the transmembrane region of E2 revealed that the high hydrophobicity of the E2 transmembrane region was the main reason for its inability to express. By mutating an amino acid to reduce the hydrophobicity of the transmembrane region, it was found that the full-length mutant of E2 (E2FL-muta3 or E2FL-muta4) could be expressed. The expressed full-length mutant E2 could also localize to the cell membrane. Mice immunized with a PRV vector vaccine expressing E2FL-muta3 or E2FL-muta4 devel-oped specific cellular immunity to the E2 protein and stimulated higher levels of E2 antibody than mice immunized with a PRV vector expressing truncated E2. After immunizing the rabbits, the lethal challenge by PRV-ZJ2013 and the febrile response elicited by CSFV were simultaneously prevented. These results suggest that rPRV-dTK/gE-E2FL-muta4 is a promising bivalent vaccine against CSFV and PRV infections.

分类号:

  • 相关文献
作者其他论文 更多>>